ProPhase Labs (PRPH) Earnings (2010 - 2025)
ProPhase Labs (PRPH) earnings from Jun 30, 2010 to Sep 30, 2025. The TTM ProPhase Labs (PRPH) earnings is -$42M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
ProPhase Labs (PRPH) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +50.27% |
| 5 Years TTM | +91.48% |
| 10 Years TTM | +29.98% |
| All Time TTM | +29.65% |
Annual Earnings change of ProPhase Labs (PRPH)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$7.34M | -86.24% |
| 2024 | -$53M | +218.00% |
| 2023 | -$17M | -190.90% |
| 2022 | $18M | +194.42% |
| 2021 | $6.27M | -395.75% |
| 2020 | -$2.12M | -32.70% |
| 2019 | -$3.15M | +81.03% |
| 2018 | -$1.74M | -104.29% |
| 2017 | $41M | -1514.29% |
| 2016 | -$2.87M | +127.78% |
| 2015 | -$1.26M | -83.91% |
| 2014 | -$7.83M | -2009.76% |
| 2013 | $410K | -137.61% |
| 2012 | -$1.09M | -59.78% |
| 2011 | -$2.71M | -22.57% |
| 2010 | -$3.50M | -8.85% |
| 2009 | -$3.84M | N/A |
Comparison ProPhase Labs (PRPH) five years earnings CAGR with competitors
ProPhase Labs (PRPH) five years earnings CAGR is 91.63%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| NOTV | Inotiv, Inc. Common Stock | 105.11% | +14.71% |
| IQV | IQVIA Holdings Inc | 27.63% | -69.85% |
| MEDP | Medpace Holdings Inc | 23.58% | -74.27% |
| ISPC | iSpecimen Inc | 17.65% | -80.73% |
| PSNL | Personalis Inc | 16.49% | -82.00% |
| BNR | Burning Rock Biotech Ltd | 15.43% | -83.16% |
| WAT | Waters Corp | 15.32% | -83.28% |
| IMDX | Insight Molecular Diagnostics Inc | 12.87% | -85.96% |
| IDXX | Idexx Laboratories Inc | 10.19% | -88.88% |
| A | Agilent Technologies Inc | 8.86% | -90.33% |
| MTD | Mettler-Toledo International Inc | 8.29% | -90.95% |
| MYNZ | Mainz Biomed N.V. | 6.76% | -92.63% |
| ILMN | Illumina Inc | 6.25% | -93.18% |
| GH | Guardant Health Inc | 6.12% | -93.32% |
| MDXH | MDxHealth SA | 4.58% | -95.01% |
| XGN | Exagen Inc | 3.92% | -95.73% |
| QGEN | Qiagen NV | 3.42% | -96.27% |